IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,427,000 | +10.1% | 77,480 | -7.9% | 0.03% | +6.7% |
| Q2 2022 | $3,114,000 | -42.3% | 84,115 | -42.2% | 0.03% | -49.2% |
| Q1 2022 | $5,394,000 | +8.5% | 145,615 | -10.9% | 0.06% | +5.4% |
| Q4 2021 | $4,973,000 | +19.5% | 163,424 | +57.8% | 0.06% | +93.1% |
| Q1 2017 | $4,162,000 | -12.6% | 103,538 | +4.0% | 0.03% | -17.1% |
| Q4 2016 | $4,761,000 | -15.7% | 99,550 | -35.4% | 0.04% | -23.9% |
| Q3 2016 | $5,648,000 | +42.9% | 154,152 | -9.1% | 0.05% | +31.4% |
| Q2 2016 | $3,952,000 | – | 169,676 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |